Search filters

List of works by Aaron N Hata

Alginate-based 3D cancer cell culture for therapeutic response modeling

scientific article published on 18 March 2021

Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer.

scientific article

Characterization of a rabbit kidney prostaglandin F(2{alpha}) receptor exhibiting G(i)-restricted signaling that inhibits water absorption in the collecting duct.

scientific article

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

scientific article published on 3 May 2004

Distinct evolutionary paths to TKI resistance in NSCLC.

scientific article published on 23 August 2016

EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis.

scientific article published on 25 May 2016

Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

scientific journal article

Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor ⬇️

scientific article (publication date: August 2003)

Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor

scientific article

Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers

scientific article published on 27 March 2014

Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor

scientific article published on May 2015

IR and Raman spectra of beta''-(BEDT-TTF)(2)RCH(2)SO(3) (R = SF(5), CF(3)): dimerization related to hydrogen bonding

scientific article published on 12 March 2009

Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2

scientific article

Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases.

scientific article published in November 2016

Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models

scientific article

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

scientific article

mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1.

scientific article published on 25 October 2013

Paulina is supported by:

About Paulina

Help